What is Organigram Global's operating income?

Organigram Global's total operating income in 2025 was -$12.86 million, based on the following breakdown: Total Gross Profit: $38.23 million Total Operating Expenses: $51.09 million

Organigram Global (OGI) Financials

$0.97 -0.01 (-1.47%)

Closing price 07/10/2026 04:00 PM Eastern

Extended Trading

$0.97 +0.01 (+0.67%)

As of 07/10/2026 07:56 PM Eastern

Compare

Annual Income Statements for Organigram Global

This table shows Organigram Global's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2024	2025
Period end date	8/31/2018	8/31/2019	8/31/2020	8/31/2021	8/31/2022	9/30/2024	9/30/2025
Net Income / (Loss) Attributable to Common Shareholders	16	-5.98	-104	-104	-11	-34	-24
Consolidated Net Income / (Loss)	16	-7.17	-104	-104	-11	-34	-18
Net Income / (Loss) Continuing Operations	17	-5.98	-81	-104	-7.35	-26	-24
Total Pre-Tax Income	21	-3.25	-112	-104	-11	-34	-28
Total Operating Income	28	4.01	-112	-73	-33	-26	-13
Total Gross Profit	40	36	-43	-23	8.96	35	38
Total Revenue	9.58	61	67	63	100	118	164
Operating Revenue	9.58	61	67	63	100	118	164
Total Cost of Revenue	4.26	32	81	85	91	83	126
Operating Cost of Revenue	4.26	32	81	85	91	83	126
Total Operating Expenses	12	25	68	50	42	61	51
Selling, General & Admin Expense	7.54	14	25	26	33	38	43
Research & Development Expense	-	-	-	2.89	4.55	8.29	7.86
Other Operating Expenses / (Income)	-	-	-	-	-3.66	-	-4.22
Restructuring Charge	-	-	-	-	-	-	4.72
Other Special Charges / (Income)	-	-	-	-	4.79	-	0.01
Total Other Income / (Expense), net	-6.66	-7.26	-6.91	-31	25	0.04	-11
Interest Expense	7.78	-	4.61	2.35	0.33	-	-0.83
Interest & Investment Income	1.12	-	-0.67	-0.21	-	-	0.48
Other Income / (Expense), net	0.00	-7.26	-1.62	-28	26	0.04	-13
Other Adjustments to Consolidated Net Income / (Loss)	-	-	-	-	-	-	0.00
Basic Earnings per Share	$0.17	-	($0.79)	($0.51)	($0.19)	($0.35)	($0.14)
Weighted Average Basic Shares Outstanding	-	156.20M	156.20M	298.79M	-	108.59M	134.46M
Diluted Earnings per Share	$0.14	-	($0.79)	($0.51)	($0.18)	($0.35)	($0.14)
Weighted Average Diluted Shares Outstanding	-	156.20M	156.20M	298.79M	-	108.59M	134.46M
Weighted Average Basic & Diluted Shares Outstanding	-	156.20M	156.20M	298.79M	-	108.59M	134.46M

No quarterly income statements for Organigram Global are available.

This table details how cash moves in and out of Organigram Global's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2024	2025
Period end date	8/31/2018	8/31/2019	8/31/2020	8/31/2021	8/31/2022	9/30/2024	9/30/2025
Net Change in Cash & Equivalents	41	-5.64	-18	24	71	60	79
Net Cash From Operating Activities	-9.79	-25	37	56	71	9.53	79
Net Cash From Continuing Operating Activities	-9.44	-25	37	56	71	9.53	79
Net Income / (Loss) Continuing Operations	17	-7.14	-104	-104	0.00	-34	0.00
Depreciation Expense	2.72	6.69	14	25	19	8.94	13
Non-Cash Adjustments To Reconcile Net Income	6.65	16	114	123	41	23	56
Changes in Operating Assets and Liabilities, net	-36	-40	14	11	11	11	9.45
Net Cash From Investing Activities	-76	-25	-104	-89	0.00	-3.90	0.64
Net Cash From Continuing Investing Activities	-76	-25	-104	-89	0.00	-3.90	0.64
Sale and/or Maturity of Investments	102	57	0.10	40	-	0.00	0.64
Net Cash From Financing Activities	126	44	49	50	0.00	80	0.00
Net Cash From Continuing Financing Activities	85	44	49	50	0.00	80	0.00
Issuance of Preferred Equity	-	-	-	-	-	-	0.00

No quarterly cash flow statements for Organigram Global are available.

This table presents Organigram Global's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	8/31/2018	8/31/2019	8/31/2020	8/31/2021	8/31/2022	9/30/2023	9/30/2024	9/30/2025
Total Assets	233	322	334	439	441	221	302	404
Total Current Assets	157	147	131	207	169	115	183	192
Cash & Equivalents	42	36	19	44	52	25	79	20
Restricted Cash	-	-	-	25	-	0.00	19	40
Short-Term Investments	58	0.29	38	102	23	-	0.61	0.59
Accounts Receivable	2.88	13	13	17	35	22	27	47
Inventories, net	35	70	51	29	38	47	50	76
Prepaid Expenses	2.60	13	5.17	5.51	6.39	8.13	6.75	8.38
Plant, Property, & Equipment, net	76	164	190	187	198	73	0.00	0.00
Total Noncurrent Assets	0.00	10	13	21	73	32	119	212
Goodwill	-	-	-	-	-	7.85	0.00	38
Intangible Assets	0.00	1.56	1.36	14	43	-	5.99	35
Other Noncurrent Operating Assets	-	0.44	6.70	2.53	25	14	113	139
Total Liabilities & Shareholders' Equity	233	322	334	439	441	221	302	404
Total Liabilities	91	76	104	59	53	20	75	153
Total Current Liabilities	8.67	33	22	21	42	17	39	91
Accounts Payable	8.29	30	13	15	31	15	35	64
Other Current Liabilities	0.05	-	0.00	5.73	9.87	1.72	4.61	27
Total Noncurrent Liabilities	82	43	82	38	11	3.25	36	62
Other Noncurrent Operating Liabilities	-	0.84	2.19	38	7.63	0.57	36	62
Total Equity & Noncontrolling Interests	142	246	230	380	388	201	226	251
Total Preferred & Common Equity	142	246	230	380	388	201	226	251
Total Common Equity	142	246	230	380	388	201	226	251
Common Stock	122	239	323	579	588	574	631	661
Retained Earnings	0.58	-6.60	-111	-218	-221	-398	-432	-437
Accumulated Other Comprehensive Income / (Loss)	0.00	-0.03	0.04	-0.06	-0.06	-0.12	-0.05	0.43
Other Equity Adjustments	20	13	18	20	22	25	27	27

No quarterly balance sheets for Organigram Global are available.

This table displays calculated financial ratios and metrics derived from Organigram Global's official financial filings.

Metric	2018	2019	2020	2021	2022	2024	2025
Period end date	8/31/2018	8/31/2019	8/31/2020	8/31/2021	8/31/2022	9/30/2024	9/30/2025
DEI Shares Outstanding	0.00	156,196,347.00	156,196,347.00	298,786,023.00	298,786,023.00	-	134,461,029.00
DEI Adjusted Shares Outstanding	0.00	39,049,087.00	39,049,087.00	74,696,506.00	74,696,506.00	-	134,461,029.00
DEI Earnings Per Adjusted Shares Outstanding	0.00	-0.15	-2.67	-1.39	-0.15	-	-0.18
Growth Metrics	-	-	-	-	-	-	-
Revenue Growth	0.00%	535.86%	9.34%	-5.79%	59.24%	0.00%	38.43%
EBITDA Growth	0.00%	-88.85%	-2,997.96%	23.17%	115.70%	0.00%	23.99%
EBIT Growth	0.00%	-111.60%	-3,380.57%	10.81%	93.05%	0.00%	0.20%
NOPAT Growth	0.00%	-87.45%	-2,885.22%	34.82%	55.01%	0.00%	50.00%
Net Income Growth	0.00%	-145.34%	-1,357.41%	0.85%	89.47%	0.00%	47.14%
EPS Growth	0.00%	0.00%	0.00%	35.36%	89.47%	0.00%	60.54%
Operating Cash Flow Growth	0.00%	-153.88%	250.40%	48.88%	27.74%	0.00%	725.54%
Free Cash Flow Firm Growth	0.00%	0.00%	35.27%	99.58%	-32,645.25%	0.00%	0.00%
Invested Capital Growth	0.00%	142.87%	5.69%	-19.37%	48.77%	0.00%	48.82%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
EPS Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Profitability Metrics	-	-	-	-	-	-	-
Gross Margin	415.42%	59.78%	-65.08%	-35.87%	8.97%	29.73%	23.34%
EBITDA Margin	321.38%	5.64%	-149.39%	-121.83%	12.01%	-14.73%	-7.77%
Operating Margin	292.99%	6.58%	-167.65%	-115.99%	-32.77%	-22.32%	-7.85%
EBIT Margin	292.99%	-5.34%	-170.08%	-161.03%	-7.03%	-22.29%	-15.65%
Profit (Net Income) Margin	165.04%	-11.77%	-156.87%	-165.11%	-10.92%	-28.43%	-10.86%
Tax Burden Percent	73.85%	220.27%	92.86%	100.00%	99.39%	100.00%	64.26%
Interest Burden Percent	76.28%	100.00%	99.33%	102.53%	156.26%	127.57%	107.91%
Effective Tax Rate	20.35%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	21.99%	1.61%	-30.78%	-21.62%	-8.76%	-14.47%	-5.67%
ROIC Less NNEP Spread (ROIC-NNEP)	38.11%	52.28%	-193.55%	54.26%	-18.56%	0.88%	5.34%
Return on Net Nonoperating Assets (RNNOA)	-10.88%	-5.31%	-13.16%	-12.34%	5.92%	-0.38%	-1.78%
Return on Equity (ROE)	11.11%	-3.70%	-43.94%	-33.96%	-2.84%	-14.85%	-7.45%
Cash Return on Invested Capital (CROIC)	0.00%	-81.73%	-36.31%	-0.16%	-47.97%	0.00%	-44.91%
Operating Return on Assets (OROA)	12.04%	-1.17%	-34.54%	-26.14%	-1.60%	-10.09%	-7.27%
Return on Assets (ROA)	6.78%	-2.58%	-31.86%	-26.80%	-2.48%	-12.88%	-5.04%
Return on Common Equity (ROCE)	11.11%	-3.70%	-43.94%	-33.96%	-2.84%	-14.85%	-7.45%
Return on Equity Simple (ROE_SIMPLE)	11.11%	-2.92%	-45.46%	-27.24%	-2.81%	-14.85%	0.00%
Net Operating Profit after Tax (NOPAT)	22	2.81	-78	-51	-23	-18	-9.00
NOPAT Margin	233.36%	4.61%	-117.35%	-81.19%	-22.94%	-15.62%	-5.50%
Net Nonoperating Expense Percent (NNEP)	-16.12%	-50.67%	162.77%	-75.87%	9.80%	-15.34%	-11.01%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-8.16%	-3.59%
Cost of Revenue to Revenue	44.45%	52.45%	120.98%	135.87%	91.03%	70.27%	76.66%
SG&A Expenses to Revenue	78.69%	22.93%	37.70%	41.86%	32.81%	32.62%	26.09%
R&D to Revenue	0.00%	0.00%	0.00%	4.60%	4.56%	7.01%	4.80%
Operating Expenses to Revenue	122.43%	40.97%	102.56%	80.11%	41.74%	52.05%	31.19%
Earnings before Interest and Taxes (EBIT)	28	-3.25	-113	-101	-7.03	-26	-26
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	31	3.43	-99	-76	12	-17	-13
Valuation Ratios	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	10.71	3.43	8.39	3.30	0.75	0.76
Price to Tangible Book Value (P/TBV)	0.00	10.78	3.45	8.70	3.71	0.77	1.07
Price to Revenue (P/Rev)	0.00	43.19	11.82	50.87	12.80	1.44	1.17
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	10.66	3.14	14.36	3.85	0.56	0.69
Enterprise Value to Revenue (EV/Rev)	0.00	43.21	12.29	48.16	12.05	0.61	0.80
Enterprise Value to EBITDA (EV/EBITDA)	0.00	766.58	0.00	0.00	100.30	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	937.91	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	21.89	54.29	16.93	0.69	1.66
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-
Debt to Equity	0.54	0.15	0.38	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.53	0.14	0.35	0.00	0.00	0.00	0.00
Financial Leverage	-0.29	-0.10	0.07	-0.23	-0.32	-0.44	-0.33
Leverage Ratio	1.64	1.43	1.38	1.27	1.15	1.22	1.48
Compound Leverage Factor	1.25	1.43	1.37	1.30	1.79	1.56	1.60
Debt to Total Capital	34.95%	13.16%	27.79%	0.06%	0.05%	0.01%	0.00%
Short-Term Debt to Total Capital	0.15%	0.93%	2.80%	0.02%	0.02%	0.00%	0.00%
Long-Term Debt to Total Capital	34.80%	12.23%	24.99%	0.05%	0.03%	0.01%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	65.05%	86.84%	72.21%	99.94%	99.95%	99.99%	100.00%
Debt to EBITDA	2.48	10.85	-0.89	0.00	0.02	0.00	0.00
Net Debt to EBITDA	-0.77	0.36	-0.31	2.22	-6.26	5.67	0.00
Long-Term Debt to EBITDA	2.47	10.08	-0.80	0.00	0.01	0.00	0.00
Debt to NOPAT	3.42	13.27	-1.13	0.00	-0.01	0.00	0.00
Net Debt to NOPAT	-1.07	0.44	-0.40	3.34	3.28	5.34	0.00
Long-Term Debt to NOPAT	3.40	12.33	-1.02	0.00	-0.01	0.00	0.00
Altman Z-Score	0.00	21.25	3.54	31.75	14.36	0.09	-0.27
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-
Current Ratio	18.06	4.47	5.85	9.92	4.01	5.57	2.12
Quick Ratio	11.89	1.49	3.15	7.80	2.62	3.07	0.74
Cash Flow Metrics	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-142	-92	-0.38	-126	0.00	-71
Operating Cash Flow to CapEx	-22.51%	-30.47%	63.09%	597.34%	0.00%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	-20.00	-0.16	-383.00	0.00	0.00
Operating Cash Flow to Interest Expense	-1.26	0.00	8.11	23.73	216.93	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	-6.85	0.00	-4.74	19.75	216.93	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-
Asset Turnover	0.04	0.22	0.20	0.16	0.23	0.45	0.46
Accounts Receivable Turnover	3.33	7.62	5.10	4.20	3.82	4.75	4.42
Inventory Turnover	0.12	0.61	1.33	2.13	2.69	1.72	1.99
Fixed Asset Turnover	0.13	0.51	0.38	0.33	0.52	0.00	0.00
Accounts Payable Turnover	0.51	1.65	3.68	6.00	3.93	3.35	2.54
Days Sales Outstanding (DSO)	109.71	47.91	71.62	86.96	95.53	76.79	82.54
Days Inventory Outstanding (DIO)	2,970.80	597.77	273.84	171.28	135.50	212.59	183.12
Days Payable Outstanding (DPO)	711.11	220.60	99.06	60.88	92.79	108.98	143.82
Cash Conversion Cycle (CCC)	2,369.41	425.08	246.40	197.36	138.24	180.40	121.84
Capital & Investment Metrics	-	-	-	-	-	-	-
Invested Capital	102	247	261	210	313	128	190
Invested Capital Turnover	0.09	0.35	0.26	0.27	0.38	0.93	1.03
Increase / (Decrease) in Invested Capital	0.00	145	14	-51	103	0.00	62
Enterprise Value (EV)	0.00	2,632	818	3,021	1,204	72	130
Market Capitalization	0.00	2,630	787	3,191	1,279	170	191
Book Value per Share	$0.00	$1.57	$1.47	$2.43	$1.30	$2.09	$2.31
Tangible Book Value per Share	$0.00	$1.56	$1.46	$2.35	$1.16	$2.03	$1.64
Total Capital	219	283	318	380	388	226	251
Total Debt	76	37	88	0.25	0.18	0.02	0.00
Total Long-Term Debt	76	35	80	0.18	0.12	0.02	0.00
Net Debt	-24	1.23	31	-170	-75	-99	-61
Capital Expenditures (CapEx)	43	82	59	9.32	0.00	0.00	0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	48	81	60	16	52	60	40
Debt-free Net Working Capital (DFNWC)	148	117	117	186	127	159	101
Net Working Capital (NWC)	148	114	108	186	127	159	101
Net Nonoperating Expense (NNE)	6.54	9.97	26	53	-12	15	8.77
Net Nonoperating Obligations (NNO)	-41	1.23	31	-170	-75	-99	-61
Total Depreciation and Amortization (D&A)	2.72	6.69	14	25	19	8.94	13
Debt-free, Cash-free Net Working Capital to Revenue	501.42%	133.20%	89.86%	24.97%	51.85%	51.11%	24.72%
Debt-free Net Working Capital to Revenue	1,547.87%	192.32%	175.95%	296.13%	127.26%	134.59%	61.73%
Net Working Capital to Revenue	1,544.48%	188.00%	162.59%	296.03%	127.20%	134.59%	61.73%
Earnings Adjustments	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	($0.27)	($3.16)	($2.04)	($0.18)	($0.35)	($0.14)
Adjusted Weighted Average Basic Shares Outstanding	0.00	39.05M	39.05M	74.70M	0.00	108.59M	134.46M
Adjusted Diluted Earnings per Share	$0.00	($0.27)	($3.16)	($2.04)	($0.18)	($0.35)	($0.14)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	39.05M	39.05M	74.70M	0.00	108.59M	134.46M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	39.05M	39.05M	74.70M	0.00	108.59M	134.46M
Normalized Net Operating Profit after Tax (NOPAT)	22	2.81	-57	-45	-17	-18	-5.69
Normalized NOPAT Margin	233.36%	4.61%	-85.28%	-71.61%	-17.31%	-15.62%	-3.48%
Pre Tax Income Margin	223.49%	-5.34%	-168.94%	-165.11%	-10.99%	-28.43%	-16.89%
Debt Service Ratios	-	-	-	-	-	-	-
EBIT to Interest Expense	3.61	0.00	-24.57	-43.07	-21.44	0.00	0.00
NOPAT to Interest Expense	2.87	0.00	-16.95	-21.71	-69.93	0.00	0.00
EBIT Less CapEx to Interest Expense	-1.98	0.00	-37.42	-47.04	-21.44	0.00	0.00
NOPAT Less CapEx to Interest Expense	-2.72	0.00	-29.81	-25.69	-69.93	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	-32.53%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

No quarterly metrics and ratios for Organigram Global are available.

Financials Breakdown Chart

Organigram Global Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Organigram Global's financial year ends in September. Their financial year 2025 ended on September 30, 2025.

Organigram Global's net income appears to be on an upward trend, with a most recent value of -$17.78 million in 2025, falling from $15.81 million in 2018. The previous period was -$33.63 million in 2024. See Organigram Global's forecast for analyst expectations on what's next for the company.

Organigram Global's total operating income in 2025 was -$12.86 million, based on the following breakdown:

Total Gross Profit: $38.23 million
Total Operating Expenses: $51.09 million

Over the last 6 years, Organigram Global's total revenue changed from $9.58 million in 2018 to $163.77 million in 2025, a change of 1,609.9%.

Organigram Global's total liabilities were at $153.00 million at the end of 2025, a 102.9% increase from 2024, and a 68.3% increase since 2018.

In the past 7 years, Organigram Global's cash and equivalents has ranged from $18.87 million in 2020 to $79.01 million in 2024, and is currently $20.25 million as of their latest financial filing in 2025.

Over the last 6 years, Organigram Global's book value per share changed from 0.00 in 2018 to 2.31 in 2025, a change of 230.9%.

Related Companies

Financial statements for NASDAQ:OGI last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Organigram Global (OGI) Financials

Financials Breakdown Chart

Organigram Global Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Organigram Global (OGI) Financials

Annual Income Statements for Organigram Global

Quarterly Income Statements for Organigram Global

Annual Cash Flow Statements for Organigram Global

Quarterly Cash Flow Statements for Organigram Global

Annual Balance Sheets for Organigram Global

Quarterly Balance Sheets for Organigram Global

Annual Metrics And Ratios for Organigram Global

Quarterly Metrics And Ratios for Organigram Global

Financials Breakdown Chart

Organigram Global Financials - Frequently Asked Questions

When does Organigram Global's fiscal year end?

How has Organigram Global's net income changed over the last 6 years?

What is Organigram Global's operating income?

How has Organigram Global's revenue changed over the last 6 years?

How much debt does Organigram Global have?

How much cash does Organigram Global have?

How has Organigram Global's book value per share changed over the last 6 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools